• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Pulse Charter Connect Secures $2M to Build “Expedia for Organ Transplants”

by Syed Hamza Sohail 05/06/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Pulse Charter Connect (PCC) has oversubscribed a $2 million seed round to modernize and streamline the way lifesaving organs are transported across the United States. 

– The round was co-led by Ivy Ventures and Simplex Ventures, with participation from Cedars Sinai Health Ventures, Belal Badat Ventures, Techstars and strategic angel investors. This new funding brings the Chicago-based startup’s total raised to $3.3 million. 

Pulse Charter Connect Secures Funding to Revolutionize Organ Transplant Logistics

Pulse Charter Connect (PCC), often called the “Expedia for Organ Transplants,” has secured capital to scale operations, enhance its proprietary logistics software, and expand its national footprint. PCC’s first-of-its-kind platform increases operational efficiency by seamlessly connecting transplant centers with air and ground fleets, ensuring the safe and efficient transportation of organs and surgical teams.

Founded in 2022 by Laura Epstein, a former aerospace engineer and ex-FAA, PCC was born out of Epstein’s firsthand observations of inefficiencies during a consulting project at the University of Chicago Booth School of Business, where she pursued her MBA. Drawing on her aviation and logistics background, Epstein developed a technology-driven solution to replace the slow, manual coordination that still dominates organ transport today.

The urgency of PCC’s mission is clear: each day, 17 people die waiting for a transplant. While approximately 45,000 organ transplants are performed annually in the U.S., more than 100,000 patients remain on the national waitlist. PCC addresses this gap by streamlining scheduling, optimizing routing, enabling real-time tracking, and ensuring clear communication among donor hospitals, transplant centers, and transport partners.

Since launching in April 2024, Pulse Charter Connect has already facilitated organ transports that saved over 65 lives across the Midwest and Mid-Atlantic regions. The startup is a graduate of Techstars, Tampa Bay Wave, and Cedars Sinai Accelerator, and has earned multiple awards and top placements at U.S. pitch competitions.

Scott Kraege, Managing Partner at Ivy Ventures, praised PCC’s mission, noting, “Laura and the Pulse team are tackling one of the most pressing challenges in healthcare logistics—with the speed, precision, and transparency that should be mandatory.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |